Design, Synthesis, and Antimalarial Evaluation of New Spiroacridine Derivatives.

ABSTRACT: Background/Objectives: Malaria is a tropical disease mainly caused by Plasmodium falciparum and represents a global public health problem, with over 200 million cases and 500 thousand deaths reported worldwide. Considering its treatment limitations, it is essential to develop new compounds against malaria. In this context, acridine derivatives are privileged structures. Methods: Thus, new spiroacridines containing N-acylhydrazone (AMTAC) and N-phenylacetamide (ACMD) were synthesized and evaluated in malaria and cytotoxicity assays, as well as in silico studies. Results: As a result, five spiroacridines showed inhibitory activity over 70% against the P. falciparum 3D7-GFP strain at 10 μM, along with an IC₅₀ ran

SUBMITTER: Cavalcanti MAT 

PROVIDER: S-EPMC12730060 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature